The Inspirational Quest to Eradicate Cancer

The world-renowned Thoracic Oncologist, Dr. Gerold Bepler, joined I Don’t Care’s Kevin Stevenson for a conversation that was no less than inspirational. Dr. Bepler, President and CEO of the Karmanos Cancer Institute, has a mission; to eradicate cancer. It’s more than a dream for Dr. Bepler; he believes it will be a reality one day.

Dr. Bepler arrived from Germany to the United States in 1983. Following a post-doctoral fellowship at the National Cancer Institute, the starting point for his journey into lung cancer research. This career path took Dr. Bepler through many stops along the way, and in 2010 he joined the Karmanos Cancer Institute.

The mission to eradicate cancer got a boost in 1971 with the National Cancer Act, and Dr. Bepler said there’s tremendous progress towards this goal since that point. “People now diagnosed with cancer have hope,” Dr. Bepler said. “And many of them get cured of the disease and have a good quality of life. That all wouldn’t have been possible without the National Cancer Act.”

Much of the progress made to eradicating cancer at the Karmanos Cancer Institute owes a debt of gratitude to that 50-year-old law for providing necessary funding that makes such research possible.

“The Karmanos Cancer Institute became one of the NCI designated cancer centers,” Dr. Bepler said. “Very quickly, the National Cancer Institute realized just having one cancer institute in Bethesda, Maryland alone wouldn’t be able to achieve that high goal of eradicating cancer. This network established cancer centers throughout the United States.” What started as a couple of centers in the 1970s is now more than 50 comprehensive cancer centers.

The world now possesses many drugs and treatments to treat cancer through the dedication and research of institutes like the Karmanos Center. And some research led to treatments for other diseases. Dr. Bepler mentioned the Karmanos Center developed three of the first FDA-approved AIDS drugs.

More Like This Story:

The Rising Tide of Food Allergens

From an Idea to Billion Dollar Company: How a Doctor Lobbied DC for HSAs

Follow us on social media for the latest updates in B2B!

Image

Latest

private equity
Alts Innovators: UT Austin’s Dr. Ken Wiles on Private Equity
December 15, 2025

Private equity is entering a period of adjustment after decades of expansion fueled by falling interest rates and abundant capital. That long-running tailwind reversed beginning in 2022, when interest rates rose sharply, disrupting deal activity, slowing exits, and bringing renewed attention to a long-standing vulnerability in private markets: liquidity. Industry reports have highlighted softer fundraising,…

Read More
SPD
Getting SPD Teams to the Table: Why Sterile Processing Deserves a Central Role in Surgical Planning and Operations
December 15, 2025

Sterile Processing Departments (SPDs) remain the backbone of safe surgical care, yet across the country, they’re still routinely left out of early decision-making around products, construction, staffing, and case planning. As hospitals juggle tighter margins, higher patient acuity, and growing procedural demands, the consequences of excluding SPD voices become unmistakably real—showing up in daily…

Read More
WireXpert
WireXpert MP Wire Mapping Overview
December 13, 2025

In modern network installations, speed alone isn’t enough—precision is what keeps systems reliable and downtime low. Tools like the WireXpert MP cable certifier reflect how far copper cable diagnostics have evolved, moving beyond simple pass-or-fail testing into actionable insight. By running a full 500 MHz sweep on a Category 6A link, technicians can…

Read More
Why Connectivity Has Become the Cornerstone of Modern Industrial Automation
December 11, 2025

Industrial automation is in the middle of a profound shift, as manufacturers push beyond basic control toward fully connected, data-driven operations that bridge the plant floor and the enterprise. What began years ago as early experiments in digital transformation—simply getting PLC data into IT systems—has now accelerated into a critical business imperative fueled by…

Read More